Page 25 - The DHEA Debate - Life Extensions Magazine
P. 25

112. Calo L, Castrignano R, Davis PA, et al. Role of insulin-like growth factor-I in primary
               osteoporosis: a correlative study. J Endocrinol Invest. 2000 Apr;23(4):223-7
               113. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth
               factor-I regulates brain amyloid- B levels. Nat Med. 2002 Dec;8(12):1390-7.
               114. Ruiz-Torres A, Soares de Meo Kirzner M. Aging and longevity are related to growth
               hormone/insulin-like growth factor-I secretion. Gerontology. 2002 Nov; 48(6):401-7.
               115. Yoshida S, Honda A, Matsuzaki Y, et al. Antiproliferative action of endogenous
               dehydroepiandrosterone metabolites on human cancer cell lines. Steroids. 2003 Jan;68(1):73-
               83.

               116. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR.
               Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and
               nongenomic mechanisms. Endocrinology. 2003 Aug;144(8):3449-55.

               117. Postmenopausal hormone therapy: cardiovascular risks. Prescrire Int. 2003 Apr;12(64):65-
               9.

               118. Jusko WJ, Blum RA, Meno-Tetang, Guy ML, Schwartz KE. Effects of oral dehy-
               droepiandrosterone on single dose pharmacokinetics or oral prednisone and cortisol
               suppression in normal women. J Clin Pharmacol. 2001;41(11):1195-1205.
               119. Bernardi F, Pieri M, Stomati M, et al. Effect of different hormonal replacement therapies on
               circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
               Gynecol Endocrinol. 2003 Feb;17(1):65-77.
               120. Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H.
               Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells:
               correlation between bone mineral density and serum DHEA-sulfate concentration in
               postmenopausal women, and the presence of aromatase to be enhanced by 1.25-
               dihydroxyvitamin D3 in human osteoblasts. Mech Ageing Dev. 2002 Apr 30;123(8):1107-14.

               121. Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR. Oral
               dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-
               releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early
               and late postmenopausal women. Fertil Steril. 2001 Aug;76(2):241-8.
               122. Kalimi M, Regelson W, eds. The Biological Role of Dehydroepiandrosterone (DHEA).
               Berlin:Walter de Gruyter; 1990.
               123. Legrain S, Massien C, Lahlou N, et al. Dehydroepiandrosterone replacement
               administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J
               Clin Endocrinol Metab. 2000 Sep;85(9):3208-17.
               124. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate,
               and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci
               USA. 2000 Apr 11;97(8):4279-84.

               125. Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on
               psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet.
               1999 Dec;67(3):169-74.
               126. Copeland JL, Consitt LA, Tremblay MS. Hormonal responses to endurance and resistance
               exercise in females aged 19-69 years. J Gerontol A Biol Sci Med Sci. 2002 Apr;57(4):B158-65.
   20   21   22   23   24   25   26   27   28